Klaus is a Partner and member of the senior leadership team at ClearView, with broad experience across the biopharmaceutical value chain. He has diverse expertise in corporate strategy and transformation, therapeutic area, disease and asset-level growth strategies as well as go-to-market and launch excellence. He led strategic engagements across a broad range of therapeutic areas, primary and specialty care. His work spans biotechs, mid-sized and large biopharmas as well as pharmacy and hospital chains.
Klaus has over 12 years of experience within life science consulting. Prior to ClearView, Klaus served as a partner at Boston Consulting Group driving the commercial strategy business.
He received his MD and Ph.D. from University of Regensburg (Germany) and gained practical experience at the Swiss Olympic Medical Center in Zurich (Switzerland). Klaus also holds a M.Sc. in Drug Research and Management from the University of Berlin, a B.Sc. in Business Administration from the University of Regensburg, and a diploma in Health Economics from European Business School Ă–strich-Winkel.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson